MeSH D055985 - latent tuberculosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D000085343:Latent infection
0 Companies
0 Drugs
Success rate
D014376:Tuberculosis
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Sanofi | Rifapentine | Priftin | 1998-06-22 |
Clinical Trials
Historical Success Rate
Phase 1
33%2/6
Phase 2
100%3/3
Phase 3
44%4/9
Approved: 1Overall Success rate: 15%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use